John D Quisel sold $844k of IRON
Chief Executive Officer at Disc Medicine, Inc.. 12,791 shares at an average of $66.01, traded Dec 16, 2024, filed Dec 18, 2024.
Score components
- +25RoleCEO
- +23Trade size$844k at market
- +5Share of holdings soldSold 15% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-24-138086, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 16, 2024 | MOption exercise Common Stock10b5-1 | +12,791 | $1.01 | $13k | 84,856 | Dec 18, 2024 |
| Dec 16, 2024 | SOpen-market sale Common Stock10b5-1 | -219 | $64.66 | $14k | 84,637 | Dec 18, 2024 |
| Dec 16, 2024 | SOpen-market sale Common Stock10b5-1 | -5,767 | $65.58 | $378k | 78,870 | Dec 18, 2024 |
| Dec 16, 2024 | SOpen-market sale Common Stock10b5-1 | -6,305 | $66.35 | $418k | 72,565 | Dec 18, 2024 |
| Dec 16, 2024 | SOpen-market sale Common Stock10b5-1 | -500 | $67.20 | $34k | 72,065 | Dec 18, 2024 |
| Dec 16, 2024 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -12,791 | $0.00 | $0 | 225,420 | Dec 18, 2024 |
Related signals
Other insiders at Disc Medicine, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 45Moderate | IRONsell Disc Medicine, Inc. | Kevin Bitterman director | $1.9M 27,136 shares | -100% | |
| 6Weak | Disc Medicine, Inc. | Kevin Bitterman director | $135k 1,689 shares | -1% | |
| 25Weak | Disc Medicine, Inc. | Kevin Bitterman director | $4.4M 54,496 shares | -16% | |
| 37Weak | Disc Medicine, Inc. | Mona Ashiya director | $310k 5,738 shares | -1% | |
| 37Weak | Disc Medicine, Inc. | Orbimed Advisors LLC director | $310k 5,738 shares | -1% | |
| 53Moderate | Disc Medicine, Inc. | Mona Ashiya director | $2.8M 52,429 shares | -10% | |
| 53Moderate | Disc Medicine, Inc. | Orbimed Advisors LLC director | $2.8M 52,429 shares | -10% | |
| 68Notable | Disc Medicine, Inc. | Mona Ashiya director | $17M 312,384 shares | -51% | |
| 68Notable | Disc Medicine, Inc. | Orbimed Advisors LLC director | $17M 312,384 shares | -51% | |
| 54Moderate | Disc Medicine, Inc. | John D Quisel Chief Executive Officer | $304k 5,574 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.